大动脉剖析中的表观遗传学:从机制到治疗方法
Yan Tao1, Gang Li2, Yanyan Yang3
1Department of Cardiac Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China.
Life sciences
|November 8, 2023
概括
大动脉解剖 (AD) 是一种严重的疾病,缺乏有效的预防措施. 表观遗传修饰,包括DNA甲基化和非编码RNA,为新的治疗策略和早期诊断AD提供了有希望的分子标.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 大动脉剖析 (AD) 是一个重大的临床挑战,预后不佳.
- 早期诊断和有效的治疗策略对于管理这种急性大动脉紧急情况至关重要.
- 目前对阿尔茨海默氏症的治疗方法缺乏预防能力,这凸显了对潜在机制的研究的需要.
研究的目的:
- 研究表观遗传修饰在大动脉剖析的发展和进展中的作用.
- 确定潜在的分子点和治疗策略,以预防或干预AD.
- 探索新的表观遗传药物和AD的诊断方法.
主要方法:
- 关于与AD相关的基因突变和表观遗传变化的当前文献的综述.
- 对表观遗传过程的分析,包括DNA甲基化,N6-甲基氨酸,组蛋白修饰和非编码RNA (ncRNAs).
- 在AD的背景下,评估特定的表观遗传调节剂,如白醇,5-阿扎丁和维生素C.
主要成果:
- 越来越多的证据将表观遗传元素,超越基因突变,与阿尔茨海默病的发展联系起来.
- 特定的表观遗传途径,如DNA甲基化,基因素修饰和ncRNAs都与AD有关.
- ресвератрол (向SIRT1),5-阿扎丁 (向DNMT) 和维生素C (向Tet2) 显示出改善AD和血管功能障碍的潜力.
结论:
- 表观遗传机制是理解和潜在地预防AD的关键领域.
- 准表观遗传通路为开发AD的新型治疗干预提供了有希望的途径.
- 对表观遗传药物和诊断的进一步研究可能为管理大动脉剖析提供未来的选择.
相关概念视频
Aortic Regurgitation I: Introduction
10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Aneurysm I: Introduction
11
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
11
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
22
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22


